IgG autoantibodies to citrullinated proteins (ACPA) precede the development of rheumatoid arthritis (RA). HLA-DR alleles with a 5-amino acid stretch called "shared epitope (SE)" in their P4 pocket are associated with ACPA and RA. The recent article by Ting et al.
IgG autoantibodies to citrullinated proteins (ACPA) precede the development of rheumatoid arthritis (RA). HLA-DR alleles with a 5-amino acid stretch called "shared epitope (SE)" in their P4 pocket are associated with ACPA and RA. The recent article by Ting et al. (1) suggests that the basis for this association is preferential binding of citrullinated peptides by SE-positive HLA-DR molecules. It shows binding of 13 selected peptides (3 from vimentin and 2 from fibrinogen) and their 18 citrullinated variants to 3 SE-positive alleles and presents 8 crystal structures of 3 SE-positive HLA-DR alleles complexed with a citrullinated peptide.
Our binding data on 96 overlapping peptides from fibrinogen and their 71 citrullinated variants (2) and Sette's data on 200 peptides from vimentin and collagen (3) do not show preferential binding of citrullinated peptides to SE-positive HLA-DR alleles. Solving the RA/ACPA/HLA-DR association will require the identification of T cells that help the production of ACPA. In normal mice, PAD (peptidyl arginyl deiminase, the citrulli-nating enzyme) immunization triggers anti-citrullinated fibrinogen antibodies by a hapten carrier mechanism (4).
The "shared epitope binds citrullinated peptide" hypothesis requires many T helper cells specific for many citrullinated peptides. We suggest the "shared epitope binds PAD peptides" alternative, which may open the field of PAD vaccination to prevent RA.
